News Details
02/07/2026 18:29
Q-Line Biotech - Reply to Clarification- Financial results
The Exchange had sought clarification from Q-Line Biotech Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: The response of the Company is enclosed.